Xbrane Biopharma AB invites to a teleconference for investors, analysts and media on Friday, October 30th, 2026, at 09.00 a.m. CET. Xbrane will publish the company’s interim report January – September 2026, on Friday, October 30, 2026, at 8.00 a.m. CET.
Martin Åmark, CEO, and Jane Benyamin, CFO/IR, will present the interim report January – September 2026, followed by a Q&A session. The presentation will be in English.
If you wish to participate via webcast, please use the link below. Via the webcast you can ask written questions.
If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.